Cancer Drug Problem

Problem Statement/Introduction

For the majority of Americans, treatment for diagnosis is a huge financial burden. The probability of incurring a cancer diagnosis is a petrifying situation for most people. A cancer diagnosis in the United States entails a myriad of complications for a person as it is often unyielding, unwelcomed, and unexpected. In a free market economy such as the United States, commodities purchased by preference can a have wide price range based upon on what society deems is the reasonable value of the commodity. Cancer drugs prices in the United States are notorious for their expensive cost. Patented cancer medications in the United States have seen a 5 to 10 fold increase in pricing from early 2000 to contemporary (Kantarjian,

(2011). Unsupported off-label use of cancer therapies: new challenges in the era of biopharmaceuticals. Expert review of pharmacoeconomics & outcomes research, 11(5). doi:10.1586/erp.11.63

Kantarjian, H., Rajkumar, V. (2015). Why Are Cancer Drugs So Expensive in the United States, and What Are the Solutions. Mayo Clinic Proceedings, 500-504 .

Kantarjian, H., Steensma, D., Rius Sanjuan, J., Elshaug, A., Light, D. (2014). High cancer drug prices in the United States: reasons and proposed solutions. Journal of oncology practice / American Society of Clinical Oncology, 208-11. doi:10.1200/JOP.2013.001351

Lewis, J., Lipworth, W., Kerridge, I., Doran, E. (2014). Dilemmas in the compassionate supply of investigational cancer drugs. Internal Medicine Journal, 841-845. doi:10.1111/imj.12530

Quotescape. Inc. (2016). Company Mission Statements . Retrieved from Pharmaceutical Mission Statements: https://www.missionstatements.com/pharmaceuticals_mission_statements.html

Schleicher, S., Wood, N., Lee, S.,Feeley, T. (2016). How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved? Oncology, 468.

Siddiqui, S., Rajkumar, V. (2012). The high cost of cancer drugs and what we can do about it. Mayo Clinic Proceedings, 87(10),